Status:
RECRUITING
Norepinephrine on Maternal Hypotension After Combined Lumbar and Epidural Anaesthesia
Lead Sponsor:
The Third People's Hospital of Bengbu
Conditions:
Maternal Hypotension
Eligibility:
FEMALE
18-40 years
Phase:
PHASE4
Brief Summary
Norepinephrine has emerged as a potential alternative for stabilizing blood pressure during spinal anesthesia for cesarean section, purportedly maintaining maternal heart rate and cardiac output more ...
Eligibility Criteria
Inclusion
- Inclusion criteria included women undergoing elective caesarean section undergoing combined lumbar and rigid anaesthesia, healthy singleton pregnancies at full term (more than 37 weeks gestation), American Society of Anaesthesiologists physical status I or II, body weight between 50-100 kg, height between 150-180 cm, and fasting for more than 8 hours.
Exclusion
- The exclusion criteria included individuals with hypertension, cardiovascular diseases, preeclampsia, arrhythmias, diabetes mellitus, spinal cord malformations, abnormal fetal conditions, and those who declined to participate in the study.
Key Trial Info
Start Date :
July 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06498115
Start Date
July 1 2024
End Date
December 1 2024
Last Update
July 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Third People's Hospital of Bengbu
Bengbu, Anhui, China, 233000